个人简介
厉有名,内科学教授、主任医师、博士生导师，现任浙江大学医学院附属第一医院消化内科主任、学科带头人, 浙江省医学会内科学分会主任委员、浙江省医师协会内科医师分会会长, 中华医师协会消化医师分会常委和消化内镜医师分会常委、第13届中华医学会内科学分会主任委员。先后承担“十二五”国家支撑计划1项，国家自然科学基金重点项目1项，参与国家863重大项目2项,获国家专利4项,发表研究论文150余篇，研究成果先后获得国家教育部科技进步奖一等奖1项,浙江省科技进步奖一等奖1项、二等奖5项，多次获得浙江省医药卫生科技创新奖一等奖
近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
Li M, Xu C, Shi J, Ding J, Wan X, Chen D, Gao J, Li C, Zhang J, Lin Y, Tu Z, Kong X, Li Y, Yu C. Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway. Gut. 2017. doi: 10.1136/gutjnl-2017-313778. (IF:16.658)
Wan X#,Xu C#,Lin Y,Lu C, Li D, Sang J, He H,Liu X,Li Y, Yu C.Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol,2016,64(4):925-32.(IF 12.486)
Xu C, Wan X,Xu L,Weng H, Yan M, Miao M, SunY, Xu G,Dooley S, Li Y, Yu C.Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: one stone hits two birds. J Hepatol. 2015,62(6):1412-9. (IF 12.486)
Zhu JZ, Wang YM, Zhou QY, Zhu KF, Yu CH, Li YM.Systematic review with meta-analysis: alcohol consumption and the risk of colorectal adenoma.Aliment Pharmacol Ther. 2014 Aug;40(4):325-37. (IF=5.487)
Shen Z, Munker S,Zhou B, Li L,Yu C, Li Y. The accuracies of diagnosing pancrease Divisum by Magnetic Resonance Cholangiopancreatography and Endoscopic Ultrasound: A Systematic review and meta-analysis. Sci Rep. 2016.13;6:35389. (IF 4.259)
Xu C, Chen Y, Xu L, Miao M, Li Y,Yu C. Serum complement C3 levels are associated with nonalcoholic fatty liver disease indepantently of metabolic syndrome features in a Chinese population. Sci Rep. 2016.6:23279. (IF 4.259)
Wang J,Xu C, Xun Y,LuZ,Shi J,Yu C，Li Y.ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population. Sci Rep. 2015.16;5:16494. (IF 4.259)
Wang J, Zhu W, Huang S, Xu L, Miao M, Wu C, Yu C, Li Y, Xu C. Serum apoB levels independently predict the development of non-alcoholic fatty liver disease: A 7-year prospective study. Liver Int. 2017; 37(8):1202-1208. (IF:4.116)
Li L, Li G, Yu C, Shen Z, Xu C, Feng Z, Zhang X, Li Y. A role of microRNA-370 in hepatic ischaemia-reperfusion injury by targeting transforming growth factor-β receptor II. Liver Int. 2015 Apr;35(4):1124-32. (IF: 4.85)
Dai YN, Zhu JZ, Fang ZY, Zhao DJ, Wan XY, Zhu HT, Yu CH, Li YM. A case-control study: Association between serum neuregulin 4 level and non-alcoholic fatty liver disease. Metabolism. 2015 Dec;64(12):1667-73. (IF: 3.894)
Zhu JZ, Zhu HT, Dai YN, Li CX, Fang ZY, Zhao DJ, Wan XY, Wang YM, Wang F, Yu CH, Li YM. Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case-control study. Endocrine. 2016 Jan;51(1):91-100. (IF: 3.878)
Shen Z, Munker S, Luo F, Ma H, Yu C, Li Y. Effect of Non-Alcoholic Fatty Liver Disease on Estimated Glomerular Filtration Rate Could Be Dependent on Age. PLoS One. 2015 Jun 18;10(6):e0130614. (IF: 3.234)
Zhu JZ, Yan TL, Yu CH, Wan XY, Wang YM, Li YM.Is national socioeconomic status related to prevalence of irritable bowel syndrome?J Gastroenterol Hepatol. 2014 Aug;29(8):1595-602. (IF=3.627)
Shen Z, Munker S, Wang C, Xu L, Ye H, Chen H, Xu G, Zhang H, Chen L, Yu C, Li Y.Association between alcohol intake, overweight, and serum lipid levels and the risk analysis associated with the development of dyslipidemia.J Clin Lipidol. 2014 May-Jun;8(3):273-8. (IF=3.587)
Wang JW, Wan XY, Zhu HT, Lu C, Yu WL, Yu CH, Shen Z, Li YM. Lipotoxic effect of p21 on free fatty acid-induced steatosis in L02 cells.PLoS One. 2014 Apr 30;9(4):e96124. (IF= 3.534)
Chen Y, Yu C, Li Y.Physical activity and risks of esophageal and gastric cancers: a meta-analysis.PLoS One. 2014 Feb 6;9(2):e88082. (IF= 3.534)
Shen C, Wu X, Xu C, Yu C, Chen P, Li Y.Association of cholecystectomy with metabolic syndrome in a Chinese population.PLoS One. 2014 Feb 5;9(2):e88189. (IF= 3.534)
Yang L, Chen Y, Zhang B, Chen C, Yue M, Du J, Yu C, Li Y.Increased diagnostic yield of capsule endoscopy in patients with chronic abdominal pain.PLoS One. 2014 Jan 31;9(1):e87396. (IF= 3.534)
Li L, Ke Y, Yu C, Li G, Yang N, Zhang J, Li Y. Antibiotic resistance of Helicobacter pylori in Chinese children: A multicenter retrospective study over 7 years. Helicobacter. 2017; 22(3):e12373. (IF: 3.429)
Chen Y, Huang H, Xu C, Yu C, Li Y. Long Non-Coding RNA Profiling in a Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight into Pathogenesis. Int J Mol Sci. 2017; 18(1). pii: E21. (IF: 3.226)
Zhu J, Wan X, Wang Y, Zhu K, Li C, Yu C, Li Y. Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study. Endocrine. 2016 Sep 14. (IF: 3.279)
Zhu JZ, Zhu HT, Dai YN, Li CX, Fang ZY, Zhao DJ, Wan XY, Wang YM, Wang F, Yu CH, Li YM. Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case-control study. Endocrine. 2016 Jan;51(1):91-100. (IF: 3.279)
Zhu J, Wan X, Wang Y, Zhu K, Li C, Yu C, Li Y. Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study. Endocrine. 2017; 56(1): 208-211. (IF: 3.131)
京公网安备 11010802027423号